Validation of an Allergic Rhinitis Control Test in Children (ARCTEnfants)

University Hospital Center (CHU)

Status: Enrolling

Conditions: Allergic Rhinitis

Treatments: Other: Self Questionnaire

Study type: Interventional

Funder types: Other

Identifiers

NCT03075917

9762

Details and patient eligibility

About

Allergic rhinitis is a common condition that affects adults as well as children and adolescents, often with impaired quality of life. Patients often report a poor level of satisfaction with the effectiveness of their treatment and are always looking for more drug combinations to improve their symptom. Several tools exist for assessing control of allergic rhinitis, but none has been validated in teenagers or in children. A study conducted in 2008, resulted in the validation of a self-administered control test of allergic rhinitis (ARCT) in patients from 12 years of age. We propose to adapt ARCT adult to pediatric population from 5 to 11 years old.

Enrollment: 135 estimated patients

Sex: All

Ages: 5 to 11 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients aged 5 to 11 years old, consulting a practitioner for an allergic rhinitis
• Parents formulated their study participation agreement by signing the consent form.

Exclusion criteria

• Patients that are already treated for the actual episode of allergic rhinitis and are satisfied of the treatment.

Trial design

Primary purpose: Prevention

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

135 participants in 1 patient group

Experimental

Experimental group

Description:

questionnaire for allergic rhinitis control children from 5 to 11 years old who complete a self questionnaire regarding allergic rhinitis control during the consultation and after 15 days

Treatment:

Other: Self Questionnaire